Stay updated with breaking news from Nasdaq Ocup. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ocuphire Pharma (NASDAQ:OCUP – Get Rating)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued on Friday, TipRanks reports. They presently have a $26.00 target price on the stock. Separately, Zacks Investment Research raised Ocuphire Pharma from a “sell” rating to a “hold” rating in a report on Thursday. Shares […]
Met FDA-agreed Primary Endpoint with More Nyxol Subjects Gaining 3 Lines of Low Contrast Distance Vision under Dim Light Conditions Compared to Placebo ...
Ocuphire Pharma (NASDAQ:OCUP – Get Rating) announced its quarterly earnings data on Friday. The company reported ($0.35) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.35), MarketWatch Earnings reports. Ocuphire Pharma stock opened at $2.15 on Monday. Ocuphire Pharma has a one year low of $1.80 and a one year high of […]
Analysts predict that Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) will post earnings per share (EPS) of ($0.29) for the current quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Ocuphire Pharma’s earnings. The business is expected to report its next quarterly earnings report on Wednesday, March 16th. On average, analysts expect that […]
FARMINGTON HILLS, Mich, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company...